6 results
Primary Objective:To assess the impact of TOOKAD® Soluble VTP on the rate of absence of definite cancer using patients onactive surveillance as a comparison (co-primary objective A).To determine the difference in risk of treatment failure associated…
The aim of this study is to evaluate the effect of a single oral dose of TW001 on oxidative stress and pharmacokinetics with and without food. Dosing with an oral solution is considered to have major advantages over iv dosing in a chronic condition…
Primary objective:The main objective of the present trial are:• to evaluate the effect of TW001 on oxidative stress biomarkers• to evaluate the safety of TW001 in patients with Alzheimer*s DiseaseSecondary objective:The secondary objective of the…
To evaluate the long-term safety of FAB122 in patients with ALS.
To assess the effect of treatment with 100 mg of FAB122 (edaravone) on disease progression in patients with ALS.
To assess the effect of treatment with 100 mg of FAB122 (edaravone) on disease progression in patients with ALS.